Today, there is a far-reaching fact that the novel coronavirus is a lot more serious than a basic respiratory infection. Frequently it assaults the lungs, yet it can also strike anywhere from the cerebrum to the toe. Numerous specialists are centered around treating the inflammatory reactions it triggers and its ability to cause mysterious blood clots, even as they battle to enable patients to breathe.
A new study done by the researchers at Brighton and Sussex Medical School (BSMS), UK finds that COVID-19 is related to a high frequency of venous thromboembolism, blood clots in the venous circulation. More than two hundred consecutive cases of coronavirus patients were admitted to the hospital and a critical percentage of 7.7 percent were diagnosed with venous thromboembolism.
Read more- More than 90% of Australians Cannot Differentiate Between a Viral and Bacterial infection (Report)
A hematologist at Weill Cornell Medicine in New York City, Dr. Jeffrey Laurence says, “The number of clotting problems I’m seeing in the ICU [intensive care unit], all related to COVID-19, is unprecedented.”
The most common type of venous thromboembolism is pulmonary embolism, a blood clot on the lungs that was seen in more than 75 percent of these coronavirus patients. The researchers found that that the D-dimer blood test was helpful to distinguish those patients at the most noteworthy risk of venous thromboembolism when admitted to the hospital.
Venous thromboembolism (VTE) is also known as blood clots. This is underdiagnosed and serious, however, it can be prevented. It is essential to know about Venous thromboembolism (VTE) because it can transpire at any age and cause severe illness, disability, and even death in a few cases. Fortunately, it can be prevented and treated whenever found early.
A cardiac specialist at the Yale-New Haven Hospital Center, Harlan Krumholz says that one of the speculations is that once the body is so occupied with a battle against an invader, the body begins consuming the clotting factors, which can result in either blood clots or bleeding. “In Ebola, the balance was more toward bleeding. In COVID-19, it’s more blood clots.”
Purple rashes, clogged catheters, swollen legs, sudden death, and formation of mysterious blood clots inside coronavirus patients are a frequent complication of COVID-19, and analysts are simply starting to unwind why. For quite a long time, reports have poured in of the disease’s effects all through the body, a significant number of which are brought about by blood clots.
Some doctors noticed that most of their coronavirus patients were developing blood clots in the legs, even while they all were on blood thinners.
A fourth-year cardiology fellow at Columbia University in New York City, Behnood Bikdeli says, “This is like a storm of blood clots.” Anybody with a serious disease is at risk of developing mysterious blood clots, however, hospitalized patients with COVID-19 appear to be more susceptible.
Dr. Chi Eziefula is the lead author of the study and a Senior Lecturer in Infection at BSMS. In this study, she says that it is highly important to know which patients are at risk of venous thromboembolism because it is treatable with anticoagulant drugs and linked to the risk of death.
A Reader in Haematology at BSMS, Dr. Tim Chevassut says that the present study signals the significance of further research to investigate the pathological mechanisms that are specific to COVID-19. It additionally highlights the dire requirement for clinical trials to assess the role of anticoagulation treatment for the counteraction of morbidity and death from COVID-19 infection